Literature DB >> 21627349

Causative relationship between diabetes mellitus and breast cancer in various regions of Saudi Arabia: an overview.

Jamal M Arif1, Ahmad M Al-Saif, Mohammed A Al-Karrawi, Othman A Al-Sagair.   

Abstract

The unwarranted connection between diabetes mellitus and breast cancer has gained new ground in recent years. Breast cancer in Saudi females accounts for approximately 21% of all cancers and the prevalence of diabetes mellitus (DM) in Saudi females is also 21.5%. DM is diagnosed in the age group of 30+ years with possible exposure to predisposing factors like hyperinsulinemia and obesity at younger age. Further, 12% of the breast cancer cases are diagnosed in the young females aged 20-34 years. Despite the readily available access to healthcare facilities in the Kingdom, a large number of diabetics, approximately 27.9%, were unaware of having diabetes mellitus. This subpopulation is quite susceptible of developing breast cancer at later age. This review discusses common etiological and predisposing factors for breast cancer and diabetes, regional distribution and possible correlation of diabetes and cancer in Saudi Arabia.

Entities:  

Mesh:

Year:  2011        PMID: 21627349

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study.

Authors:  Avonne E Connor; Richard N Baumgartner; Kathy B Baumgartner; Richard A Kerber; Christina Pinkston; Esther M John; Gabriela Torres-Mejia; Lisa Hines; Anna Giuliano; Roger K Wolff; Martha L Slattery
Journal:  Breast Cancer Res Treat       Date:  2012-10-21       Impact factor: 4.872

Review 2.  Circulatory estrogen level protects against breast cancer in obese women.

Authors:  Zsuzsanna Suba
Journal:  Recent Pat Anticancer Drug Discov       Date:  2013-05       Impact factor: 4.169

3.  On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test.

Authors:  Lin-jie Lu; Rui-jue Wang; Liang Ran; Lu Gan; Yang Bai; Liang-bin Jin; Zi-xiang Yao; Sheng-chun Liu; Guo-sheng Ren; Kai-nan Wu; Hong-yuan Li; Ling-quan Kong
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.